Procalcitonin Monitoring Sepsis Study

Brahms AG858 enrolled

Overview

The purpose of this study is to investigate the relationship between a procalcitonin decrease over 72 hours and outcome in patients who have severe sepsis or septic shock.

Study Type

OBSERVATIONAL

Enrollment

858

Conditions

Severe Sepsis Septic Shock

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patients (i.e. \>18 years of age) diagnosed with severe sepsis or septic shock as defined in Appendix 1, who are already in the ICU or come from the ED, other wards or directly from out of hospital * Blood sample collection within 12 hours after diagnosis "severe sepsis or septic shock"No prior enrollment into this study * Written informed consent

Locations (13)

University of California Davis Health System

Sacramento, California, United States

Northwestern University

Chicago, Illinois, United States

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Outcomes

Primary Outcomes

28 day all cause mortality

participants will be followed up for 28 days

Time frame: within 28 day safter inlclusion

Secondary Outcomes

all-cause in-hospital mortality

count all death through out stay in the hospital

Time frame: mortality during hospital stay

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.